Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Treanor

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Journal of Virology|February 15, 2005
Cellular and humoral immunity following Snow Mountain virus challengeLisa Lindesmith, Christine Moe, Jacques Lependu, et al.
Vaccine|September 1, 2005
Intranasal administration of a proteosome-influenza vaccine is well-tolerated and induces serum and nasal secretion influenza antibodies in healthy human subjectsJohn Treanor, Carrie Nolan, Diane O'Brien, et al.
The Journal of Infectious Diseases|February 16, 2006
Recovery of drug-resistant influenza virus from immunocompromised patients: a case seriesMichael G Ison, Larisa V Gubareva, Robert L Atmar, et al.
Vaccine|November 26, 2009
B cell responses to H5 influenza HA in human subjects vaccinated with a drifted variantJane Baer, Felix Santiago, Hongmei Yang, et al.
Journal of Virological Methods|December 10, 2013
Use of bacteriophage particles displaying influenza virus hemagglutinin for the detection of hemagglutination-inhibition antibodiesWilliam Domm, Matthew Brewer, Steven F Baker, et al.
Viruses|November 4, 2020
A Mutated PB1 Residue 319 Synergizes with the PB2 N265S Mutation of the Live Attenuated Influenza Vaccine to Convey Temperature SensitivityAndrew Cox, Jordana Schmierer, Josephine D'Angelo, et al.
Psychosomatic Medicine|November 27, 2004
Psychosocial factors and the response to influenza vaccination in older adultsJan A Moynihan, Mark R Larson, John Treanor, et al.
Vaccine|June 22, 2020
A phase 2 study of the bivalent VLP norovirus vaccine candidate in older adults; impact of MPL adjuvant or a second doseJohn Treanor, Jim Sherwood, Jakob P Cramer, et al.
The Journal of Infectious Diseases|December 15, 2015
Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9)Mahdee Sobhanie, Yumiko Matsuoka, Sinthujan Jegaskanda, et al.
Angewandte Chemie (International Ed. in English)|May 28, 2015
Construction of an Internally B3 N3 -Doped Nanographene MoleculeMatthias Krieg, Florian Reicherter, Peter Haiss, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Journal of Virology|February 15, 2005
Cellular and humoral immunity following Snow Mountain virus challengeLisa Lindesmith, Christine Moe, Jacques Lependu, et al.
Vaccine|September 1, 2005
Intranasal administration of a proteosome-influenza vaccine is well-tolerated and induces serum and nasal secretion influenza antibodies in healthy human subjectsJohn Treanor, Carrie Nolan, Diane O'Brien, et al.
The Journal of Infectious Diseases|February 16, 2006
Recovery of drug-resistant influenza virus from immunocompromised patients: a case seriesMichael G Ison, Larisa V Gubareva, Robert L Atmar, et al.
Vaccine|November 26, 2009
B cell responses to H5 influenza HA in human subjects vaccinated with a drifted variantJane Baer, Felix Santiago, Hongmei Yang, et al.
Journal of Virological Methods|December 10, 2013
Use of bacteriophage particles displaying influenza virus hemagglutinin for the detection of hemagglutination-inhibition antibodiesWilliam Domm, Matthew Brewer, Steven F Baker, et al.
Viruses|November 4, 2020
A Mutated PB1 Residue 319 Synergizes with the PB2 N265S Mutation of the Live Attenuated Influenza Vaccine to Convey Temperature SensitivityAndrew Cox, Jordana Schmierer, Josephine D'Angelo, et al.
Psychosomatic Medicine|November 27, 2004
Psychosocial factors and the response to influenza vaccination in older adultsJan A Moynihan, Mark R Larson, John Treanor, et al.
Vaccine|June 22, 2020
A phase 2 study of the bivalent VLP norovirus vaccine candidate in older adults; impact of MPL adjuvant or a second doseJohn Treanor, Jim Sherwood, Jakob P Cramer, et al.
The Journal of Infectious Diseases|December 15, 2015
Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9)Mahdee Sobhanie, Yumiko Matsuoka, Sinthujan Jegaskanda, et al.
Angewandte Chemie (International Ed. in English)|May 28, 2015
Construction of an Internally B3 N3 -Doped Nanographene MoleculeMatthias Krieg, Florian Reicherter, Peter Haiss, et al.
Pageof 6